Search results
On an Immunotherapy Drug? Acetaminophen Makes It Less Effective, Research Says
Woman's World via Yahoo News· 1 year agoIf you or a loved one has cancer, you know by now that anti-cancer drugs are hard on the body. They...
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
2 Biotechs That Could Get Bought Out in 2024
Motley Fool via Yahoo Finance· 6 months agoBig pharma is facing another round of major patent expirations. Before the decade's end, Bristol Myers Squibb (BMS) will lose exclusivity for the...
Lack of insurance may prevent Americans from accessing best cancer drugs
United Press International via Yahoo News· 3 weeks agoA cutting-edge class of drugs is saving and extending the lives of cancer patients. But the drugs,...
Regeneron faces new biosimilar threats; an AI biotech lays off staff
BioPharma Dive via Yahoo Finance· 1 month agoBioPharma Dive is testing out a new format rounding up smaller updates from around the industry....
Novocure Crashes 43% As Critics Question Its 'Profound' Impact In Lung Cancer Treatment
Investor's Business Daily· 1 year agoA medical device from Novocure extended overall survival for lung cancer patients, but NVCR stock...
A Patent Cliff Is Coming For Bristol Myers — Can Billions In New Products Fill The Gap?
Investor's Business Daily· 1 year agoIt's a new day at Bristol Myers Squibb, according to a company executive. But BMY stock remains...
Advanced Esophageal Cancer and Immunotherapy
Verywell Health via Yahoo News· 10 months agoA Newer Treatment OptionMedically reviewed by Gagandeep Brar, MD Immunotherapy for esophageal cancer is a newer treatment approach shown to improve the...
Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?
Motley Fool· 1 year agoShares in pharmaceutical company Bristol Myers Squibb (NYSE: BMY) are up a little more than 11% over...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 1 month agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
